FORT LAUDERDALE, Fla., Sept. 23 /PRNewswire/ -- OmniComm Systems, Inc. (OTC: OMCM), one of the fastest growing companies in the EDC marketplace, today announced that Beardsworth, a full service contract research organization (CRO) who specializes in difficult therapeutic areas, has selected OmniComm's AE Reporting System to enhance its safety reporting process. AE Reporting is an advanced adverse event reporting and information management system designed for the global collection, assessment, reporting, and analysis of clinical trial and post-marketing adverse events.
Michael O'Brien, Beardsworth's President & CEO states, "We are happy to incorporate OmniComm's AE Reporting System to broaden our ability in safety reporting, which is an essential element in the services to our clients." The robust functionality within AE Reporting will automate many of the complex activities associated with drug safety, including data entry, medical review, reporting and case distribution.
"We are extremely pleased that Beardsworth has selected AE Reporting to be part of its global safety surveillance practice," commented Stephen Johnson, President & COO of OmniComm Systems, Inc. "We are committed to providing leading solutions and services across the eClinical spectrum to aid our clients with their complex clinical research needs." Last year Beardsworth implemented OmniComm's TrialMaster EDC solution for capturing and processing clinical trial data. AE Reporting will be integrated with TrialMaster, to fully automate the safety handling process from the initial capture of the AE to the submission to the FDA and other regulatory authorities.
About BeardsworthBeardsworth Consulting Group, Inc. (www.beardsworth.com) is a full-service CRO whose service offerings span all stages of drug development and clinical trial management. With a command of the complex trial, Bea